Newstral
Article
TechCrunch on 2019-01-17 15:13
IBM and Vodafone form $550M venture to develop cloud, 5G and AI business solutions
Related news
- IBM used NYPD surveillance cameras to develop facial recognition techengadget
- Vodafone und IBM tun sich im Cloud-Geschäft zusammenReuters
- IBM won’t develop facial recognition tech for mass surveillance anymorethenextweb.com
- CIBM, Global Citizen Seek Blockchain Solutions for Humanitarian Aidcoindesk.com
- KClinical Trial Management (CTM) Market Size, Status and Forecast 2021- Medidata Solutions, Mednet Solutions, IBMksusentinel.com
- IBM, CUSO CULedger Partner to Develop Blockchain Solutions for Global Credit Unionscointelegraph.com
- IBMForbes
- LClinical Trial Management (CTM) Market Growth Trends by Companies: Medidata Solutions, Parexel, BioClinica, Bio-Optronics, IBM, MedNet Solutionsliverpoolstudentmedia.com
- Riyadh Municipality Partners with IBM to Develop Blockchain for Government Servicescointelegraph.com
- IBM Will No Longer Offer Or Develop Facial Recognition Software In Pursuit Of Racial Justice ReformForbes
- IBM will no longer offer, develop, or research facial recognition technologyThe Verge
- IIBM to launch $500M AI Venture Fund while blockchain tackles AI’s energy consumptioninvezz.com
- AT&T Launches Suite of Enterprise Blockchain Solutions Using Tech From IBM, Microsoftcointelegraph.com
- LGlobal Blockchain Security Solutions Market Top Manufacturers Analysis by 2026: Oracle, IBM, Kaspersky, Gemalto, ClearSky etc.liverpoolstudentmedia.com
- KCMMS Tool Market 2021 Global Insights and Business Scenario – Maintenance Connection, eMaint, Dude Solutions, Hippo, IBMksusentinel.com
- How IBM invented solutions to keep patent work flowing during pandemicbizjournals.com
- GClinical Trial Management System Market See Huge Growth for New Normal| IBM, MedNet Solutions Inc., ArisGlobalgalleonnews.com
- WIBM makes $2B+ deal to add more AI, cloud computing solutionswraltechwire.com
- Storage Solutions From IBM, Quantum And Pure Integrate Storage And SoftwareForbes
- BenevolentAI, which uses AI to develop drugs and energy solutions, nabs $115M at $2B valuationTechCrunch